tradingkey.logo

908 Devices Inc.

MASS
View Detailed Chart

6.820USD

+0.290+4.44%
Close 09/18, 16:00ETQuotes delayed by 15 min
245.91MMarket Cap
LossP/E TTM

908 Devices Inc.

6.820

+0.290+4.44%
Intraday
1m
30m
1h
D
W
M
D

Today

+4.44%

5 Days

+19.65%

1 Month

+2.87%

6 Months

+48.91%

Year to Date

+210.00%

1 Year

+86.34%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-17

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Strong Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
49 / 207
Overall Ranking
165 / 4723
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Strong Buy
Current Rating
10.000
Target Price
+62.34%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 27.28% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 59.63M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 115.14.
Undervalued
The company’s latest PE is -11.54, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 29.86M shares, decreasing 9.87% quarter-over-quarter.
Held by Catherine Wood
Star Investor Catherine Wood holds 2.65M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.58.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
Ticker SymbolMASS
Company908 Devices Inc.
CEODr. Kevin J. Knopp, Ph.D.
Websitehttps://908devices.com/
KeyAI